Annual treatment frequencies in all eyes. by Yasuyuki Sotani (20114144)

Subjects:

Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

Subjects:

Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

Subjects:

Preoperative background characteristics of the patients. by Yasuyuki Sotani (20114144)

Subjects:

Penalty conversions yield large practical decreases, but robustness and generalizability of result are limited by data quality and sample selection. by Ryan J. Treves (13527735)

Five-year Trends in SMR for All-cause and Heart Disease Mortality (ICD-10: I20–I52). by Shinichiro Ishikawa (22493274)

Fig 6 - by Teagan McMahon (20108036)

Subjects:

The reduced virulence of Δalta1 mutants is not primarily due to a decrease in growth. by Shuhuan Zhang (748003)

Mean lipid profile (mmol/L) upon completion of the experimental period. by Elsie D. Oduor (22521785)

Trends in age-standardized death rates attributable to specific risk factors for four major female-specific cancers incidence (2000–2021) in the USA. by Ze Zhang (47230)

Subjects:

Treatment of cancer cells with vitamin D3 induced death <i>a.</i> by Vidya G. Bettada (22208808)

Parallel trend test. by Xi Gu (2632996)

Genes show significant expression change in meta-analysis and their connection with Sjogren’s syndrome and thyroid cancer. by Fanyong Kong (20700261)

“…A gene in red indicates significantly increased expression in the meta-analysis, whereas a gene in blue indicates significantly decreased expression in the meta-analysis.…”

Graphical abstract regarding program development. by Ana Beato (20489933)

Subjects:

Overview of the WeARTolerance program. by Ana Beato (20489933)

Subjects:

Phases of the intervention program. by Ana Beato (20489933)

Subjects:

Consort diagram. by Ana Beato (20489933)

Subjects:

Characteristics of the sample. by Ana Beato (20489933)

Subjects:

Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2018 ^a indicates ≥1.50 SD (17.9) from the mean (32.9... by Luke R. Cavanah (19022435)

Large state-wide variation (11.1-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2015 ^a indicates ≥1.50 SD (20.2) from the mean (36.... by Luke R. Cavanah (19022435)